CN1407113A - 均相基因矩阵 - Google Patents
均相基因矩阵 Download PDFInfo
- Publication number
- CN1407113A CN1407113A CN01126578A CN01126578A CN1407113A CN 1407113 A CN1407113 A CN 1407113A CN 01126578 A CN01126578 A CN 01126578A CN 01126578 A CN01126578 A CN 01126578A CN 1407113 A CN1407113 A CN 1407113A
- Authority
- CN
- China
- Prior art keywords
- artificial sequence
- primer
- sequence template
- reporter molecules
- template primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002068 genetic effect Effects 0.000 title claims description 34
- 239000011159 matrix material Substances 0.000 title claims description 34
- 230000003321 amplification Effects 0.000 claims abstract description 64
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 64
- 238000006243 chemical reaction Methods 0.000 claims abstract description 62
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 50
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 45
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 45
- 239000000758 substrate Substances 0.000 claims abstract description 29
- 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 13
- 239000000523 sample Substances 0.000 claims description 109
- 238000001514 detection method Methods 0.000 claims description 51
- 239000002773 nucleotide Substances 0.000 claims description 29
- 125000003729 nucleotide group Chemical group 0.000 claims description 29
- 238000002866 fluorescence resonance energy transfer Methods 0.000 claims description 25
- 230000000295 complement effect Effects 0.000 claims description 22
- 125000006850 spacer group Chemical group 0.000 claims description 18
- 239000013307 optical fiber Substances 0.000 claims description 12
- 239000000835 fiber Substances 0.000 claims description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
- 229910052761 rare earth metal Inorganic materials 0.000 claims description 3
- 239000000427 antigen Substances 0.000 claims description 2
- 102000036639 antigens Human genes 0.000 claims description 2
- 108091007433 antigens Proteins 0.000 claims description 2
- 229960002685 biotin Drugs 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- 239000002872 contrast media Substances 0.000 claims description 2
- 239000012188 paraffin wax Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 31
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 26
- 238000012360 testing method Methods 0.000 abstract description 10
- 230000035945 sensitivity Effects 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 6
- 238000003500 gene array Methods 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 90
- 230000008859 change Effects 0.000 description 46
- 238000003752 polymerase chain reaction Methods 0.000 description 35
- 238000005516 engineering process Methods 0.000 description 34
- 230000004087 circulation Effects 0.000 description 26
- 239000003795 chemical substances by application Substances 0.000 description 18
- 230000001717 pathogenic effect Effects 0.000 description 16
- 125000006853 reporter group Chemical group 0.000 description 16
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 15
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 15
- 238000011144 upstream manufacturing Methods 0.000 description 14
- 241000700605 Viruses Species 0.000 description 12
- 238000013461 design Methods 0.000 description 12
- 239000002253 acid Substances 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 230000005284 excitation Effects 0.000 description 8
- 101150090202 rpoB gene Proteins 0.000 description 8
- 229910052736 halogen Inorganic materials 0.000 description 7
- 150000002367 halogens Chemical class 0.000 description 7
- 230000007062 hydrolysis Effects 0.000 description 7
- 238000006460 hydrolysis reaction Methods 0.000 description 7
- 230000035772 mutation Effects 0.000 description 7
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 7
- 230000003416 augmentation Effects 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 238000009396 hybridization Methods 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000010839 reverse transcription Methods 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 241000700721 Hepatitis B virus Species 0.000 description 5
- 101710163270 Nuclease Proteins 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 241001493065 dsRNA viruses Species 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 201000008827 tuberculosis Diseases 0.000 description 5
- 102000053602 DNA Human genes 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000003068 static effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 3
- 102100034343 Integrase Human genes 0.000 description 3
- 101100038261 Methanococcus vannielii (strain ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 / SB) rpo2C gene Proteins 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000007421 fluorometric assay Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000007899 nucleic acid hybridization Methods 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 101150085857 rpo2 gene Proteins 0.000 description 3
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000005357 flat glass Substances 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000869 mutational effect Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- COCMHKNAGZHBDZ-UHFFFAOYSA-N 4-carboxy-3-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]benzoate Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C1=CC(C([O-])=O)=CC=C1C(O)=O COCMHKNAGZHBDZ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108091060211 Expressed sequence tag Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 238000006713 insertion reaction Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012772 sequence design Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
对照引物(c) | 突变引物(e) | |
野生型质粒(w) | Ctwc | Ctwe |
突变型质粒(m) | Ctmc | Ctme |
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011265787A CN1186457C (zh) | 2001-08-29 | 2001-08-29 | 均相基因矩阵 |
PCT/CN2002/000591 WO2003019189A1 (fr) | 2001-08-29 | 2002-08-26 | Microreseau de genes a phase homogene |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011265787A CN1186457C (zh) | 2001-08-29 | 2001-08-29 | 均相基因矩阵 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1407113A true CN1407113A (zh) | 2003-04-02 |
CN1186457C CN1186457C (zh) | 2005-01-26 |
Family
ID=4666590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011265787A Expired - Lifetime CN1186457C (zh) | 2001-08-29 | 2001-08-29 | 均相基因矩阵 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN1186457C (zh) |
WO (1) | WO2003019189A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105087772A (zh) * | 2015-06-26 | 2015-11-25 | 上海恒健生物技术有限公司 | 一种液相基因芯片检测方法、液相基因芯片及试剂盒 |
CN105087772B (zh) * | 2015-06-26 | 2018-06-01 | 上海恒健生物技术有限公司 | 一种液相基因芯片检测方法、液相基因芯片及试剂盒 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4541731B2 (ja) * | 2004-03-12 | 2010-09-08 | キヤノン株式会社 | 核酸検出方法 |
WO2008105101A1 (ja) | 2007-02-28 | 2008-09-04 | Shin-Etsu Chemical Co., Ltd. | 貼り合わせ基板の製造方法および貼り合わせ基板 |
BR112013005872A2 (pt) | 2010-09-22 | 2019-09-24 | Alios Biopharma Inc | compostos, composição farmacêutica e respectivos usos |
AU2012358804B2 (en) | 2011-12-22 | 2018-04-19 | Alios Biopharma, Inc. | Substituted phosphorothioate nucleotide analogs |
US8916538B2 (en) | 2012-03-21 | 2014-12-23 | Vertex Pharmaceuticals Incorporated | Solid forms of a thiophosphoramidate nucleotide prodrug |
EP2827876A4 (en) | 2012-03-22 | 2015-10-28 | Alios Biopharma Inc | PHARMACEUTICAL COMBINATIONS WITH A THIONUCLEOTIDE ANALOG |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1117282C (zh) * | 1999-09-03 | 2003-08-06 | 何农跃 | 聚合酶链式反应微阵列探针循环检测型生物芯片 |
EP1255860A2 (en) * | 1999-12-29 | 2002-11-13 | Mergen Ltd. | Methods for amplifying and detecting multiple polynucleotides on a solid phase support |
-
2001
- 2001-08-29 CN CNB011265787A patent/CN1186457C/zh not_active Expired - Lifetime
-
2002
- 2002-08-26 WO PCT/CN2002/000591 patent/WO2003019189A1/zh not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105087772A (zh) * | 2015-06-26 | 2015-11-25 | 上海恒健生物技术有限公司 | 一种液相基因芯片检测方法、液相基因芯片及试剂盒 |
CN105087772B (zh) * | 2015-06-26 | 2018-06-01 | 上海恒健生物技术有限公司 | 一种液相基因芯片检测方法、液相基因芯片及试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
WO2003019189A1 (fr) | 2003-03-06 |
CN1186457C (zh) | 2005-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1273611C (zh) | 使用突变dna聚合酶的高温逆转录 | |
CN1198943C (zh) | 通过裂解脱碱基位点的核酸产生可延伸的上游dna片段而鉴定核酸分子的方法 | |
CN101056883A (zh) | 包括含有嵌入性假核苷酸(ipn)的嵌入性核酸(ina)的扩增阻断剂 | |
CN1451050A (zh) | 控制水相介质的微生物质量的方法及其试剂盒 | |
CN1639357A (zh) | 检测人乳头瘤病毒mRNA的方法 | |
CN100351393C (zh) | 核苷酸多态性的检测方法 | |
CN1850981A (zh) | 切口酶扩增靶核酸序列的方法及用于扩增靶核酸序列的试剂盒及其应用 | |
CN1711357A (zh) | 用于广泛检测工业产品中的生物体的一步实时rt pcr试剂盒 | |
CN1863927A (zh) | 核酸检测分析 | |
CN1876844A (zh) | 在阵列上对遗传修饰植物特异的核苷酸序列元件的鉴定和/或定量 | |
CN1876843A (zh) | 检测突变和/或多态性的方法 | |
CN101074450A (zh) | 诊断探针检测系统 | |
CN1665938A (zh) | 检测序列差异的方法 | |
CN1977050A (zh) | 丙型肝炎病毒基因型的确定 | |
CN1723217A (zh) | 使用单核苷酸多态性组分析受损样品的方法和组合物 | |
CN100345980C (zh) | 检测乙型肝炎病毒的pcr引物组,使用该引物组检测乙型肝炎的方法以及包含该引物组的乙肝病毒检测试剂盒 | |
CN1910289A (zh) | 用于检测hiv的引物和探针 | |
CN1777684A (zh) | 用于多元结合分析的寡核苷酸对 | |
CN1169824C (zh) | M×a蛋白质的多型基因及其应用 | |
CN101045944A (zh) | 检测六种腹泻致病菌的基因芯片、制备方法及试剂盒 | |
CN101054603A (zh) | 快速测定细胞角蛋白19(ck19)的方法和其引物及探针 | |
CN1798842A (zh) | 核酸检测 | |
CN1186457C (zh) | 均相基因矩阵 | |
CN1813064A (zh) | 检测sars冠状病毒的方法 | |
CN1537954A (zh) | 表达基因分析方法以及用于表达基因分析的探针试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: STEMCELL BIOLOGICAL TECHNOLOGIES (SHANGHAI) CO., L Free format text: FORMER OWNER: CAO WEI Effective date: 20120907 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201103 XUHUI, SHANGHAI TO: 200233 XUHUI, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120907 Address after: 200233 Guiping Road, Xuhui District, No. 333, building 1, building 5, building Patentee after: Zhenjing Biotechnology (Shanghai) Co., Ltd. Address before: 201103 Hong Fu Garden, No. 3131 Hongmei Road, Shanghai, 22B Patentee before: Cao Wei |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20030402 Assignee: Zhenjing Biotechnology (Wuxi) Co., Ltd. Assignor: Zhenjing Biotechnology (Shanghai) Co., Ltd. Contract record no.: 2012990000862 Denomination of invention: Homogeneous genetic matrix Granted publication date: 20050126 License type: Exclusive License Record date: 20121203 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: CBM BIOTECHNOLOGY (SHANGHAI) CO., LTD. Free format text: FORMER NAME: STEMCELL BIOLOGICAL TECHNOLOGIES (SHANGHAI) CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 200233 Guiping Road, Xuhui District, No. 333, building 1, building 5, building Patentee after: Xibiman Biotechnology (Shanghai) Co., Ltd. Address before: 200233 Guiping Road, Xuhui District, No. 333, building 1, building 5, building Patentee before: Zhenjing Biotechnology (Shanghai) Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200312 Address after: Room 417, 4 / F, tower 2, Lippo centre, 89 Queensway, Hong Kong, China Patentee after: SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP Ltd. Address before: 200233, building 1, building 333, No. 5, Guiping Road, Shanghai, Xuhui District Patentee before: Cellular Biomedicine Group (Shanghai) Ltd. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20050126 |